Scarica l'app Stockscreener
8.08
3.32%
0.26
Abacus Life Inc Borsa (ABL) Ultime notizie
Abacus Life director Adam Gusky buys $137,537 in stock - Investing.com
ABL Tech, a subsidiary of Abacus Life, Announces a Preferred Equity Investment in Insured Connect - EIN News
Abacus Life (ABL) Expands Insurance Tech Footprint with Strategic Insured Connect Investment | ABL Stock News - StockTitan
B. Riley Comments on Abacus Life's Q1 Earnings (NASDAQ:ABL) - MarketBeat
Abacus Life's CEO on Cracking the Code of Longevity Returns - MSN
Abacus Life Targets Close of the Acquisition of Carlisle Management Company S.C.A. for December 2, 2024 with Receipt of Regulatory Non-Objection - The Manila Times
Abacus Life Targets Close of the Acquisition of Carlisle Management Company S.C.A. for December 2, 2024 with - EIN News
What is B. Riley's Forecast for Abacus Life FY2024 Earnings? - MarketBeat
Abacus Life (ABL) Continues Momentum With Strong 3rd Quarter - Barchart
Abacus life co-founder and president sells $1.25 million in stock By Investing.com - Investing.com South Africa
Abacus life co-founder and president sells $1.25 million in stock - Investing.com
Abacus Life CEO sells shares worth $16.25 million By Investing.com - Investing.com Nigeria
Abacus Life president Matthew Ganovsky sells $1.25 million in shares By Investing.com - Investing.com Nigeria
Abacus life co-founder and president McNealy sells shares for $1.25 million - Investing.com Australia
Abacus Life CEO sells shares worth $16.25 million - Investing.com India
Abacus Life Announces Successful $100 Million Offering - TipRanks
Abacus Life Announces Closing of Public Offering of 12,500,000 Shares of Common Stock - The Manila Times
Abacus Life Raises $100M in Oversubscribed Public Offering at $8.00 Per Share | ABL Stock News - StockTitan
Abacus Life’s CEO on Cracking the Code of Longevity Returns - sharewise
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series - MarketBeat
B.Riley boosts Abacus Life shares target, buy rating on stock offering - Investing.com Australia
B.Riley boosts Abacus Life shares target, buy rating on stock offering By Investing.com - Investing.com South Africa
Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 59.48%: Here's is How to Trade - MSN
Abacus Life (NASDAQ:ABL) Shares Gap DownShould You Sell? - MarketBeat
Abacus Life Announces Public Offering for Expansion - Yahoo Finance
Abacus Life Shares Fall on $100M Stock Offering - MarketWatch
Abacus Life Announces Pricing of Public Offering of Common Stock - Yahoo Finance
Abacus Life prices $100M equity offering - MSN
Abacus Life 12.5M share Spot Secondary priced at $8.00 - TipRanks
Abacus Life Launches $100M Public Offering at $8 Per Share, Plans Expansion | ABL Stock News - StockTitan
Abacus Life Announces Pricing of Public Offering of Common Stock - GlobeNewswire Inc.
Abacus Life announces 12.5M proposed public offering - MSN
Form 424B7 Abacus Life, Inc. - StreetInsider.com
Form 424B2 Abacus Life, Inc. - StreetInsider.com
Abacus Life Announces Proposed Public Offering of Common Stock - The Manila Times
Abacus Life announces offering of 12.5M shares of common stock - TipRanks
Abacus Life Launches Major 12.5M Share Public Offering for Growth & Acquisitions | ABL Stock News - StockTitan
(ABL) Long Term Investment Analysis - Stock Traders Daily
Abacus Life Faces Integration Challenges and Risks with FCF Acquisition - MSN
Head-To-Head Survey: PJT Partners (NYSE:PJT) & Abacus Life (NASDAQ:ABL) - Defense World
Royce & Associates LP Acquires 77,000 Shares of Abacus Life, Inc. (NASDAQ:ABL) - MarketBeat
Abacus Life, Inc. (NASDAQ:ABL) Shares Bought by Principal Financial Group Inc. - MarketBeat
Principal Financial Group Inc. Raises Stock Position in Abacus Life, Inc. (NASDAQ:ABL) - Defense World
Abacus Life, Inc. (NASDAQ:ABL) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Abacus Life, Inc. (NASDAQ:ABL) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
(ABLLL) Investment Report - Stock Traders Daily
Abacus Life, Inc. (NASDAQ:ABL) Sees Significant Growth in Short Interest - MarketBeat
Analyzing Abacus Life (NASDAQ:ABL) & Fifth Street Asset Management (OTCMKTS:FSAM) - Defense World
Closing Bell: Dorel Industries Inc Cl B Sv Down On Friday (DII-B) - Barchart
Dillard’s, Inc. To Report Third Quarter And Year-To-Date Results - Barchart
Winter To Be Colder: RRC, AR, CRK Stocks To Gain From Gas Demand? - Barchart
Alpha-1 Antitrypsin Deficiency Market Expected to Experience Major Growth by 2034, According to DelveInsight | Kamada Pharma, Mereo BioPharma/AstraZeneca, Grifols Therapeutics LLC, Takeda, Vertex - Barchart
1.46%
2.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):